The FDA approved Sandoz's Glatopa, the first generic version of Teva's Copaxone, a glatiramer acetate injection, 20 mg/ml one-time-daily multiple sclerosis therapy.
Glatopa is approved for the treatment of patients with relapsing forms of MS, including those who have experienced a first clinical episode and have MRI features consistent with MS.
